SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : HELIX BIOPHARMA (HBP:TSE)

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: trustmanic who wrote (44)5/24/1997 12:12:00 AM
From: burner   of 193
 
George,
I spoke with Terry Owen @ Helix yesterday and although he could not say when approvals from the HPB might occur, he is hoping to hear something soon. I believe there are 3 or 4 products that have been submitted and the company is anxious to get them to market.
The anti-infective technology is getting closer to phase one stage (animal trials), and we should see this happen before the end of the year.
Sounds like the DNA lab is establishing an awareness in the police community for accurate, expedient and independent forensic analysis.
Terry also mentioned that the public relations efforts of Tim Fussner and Barr & Wilcox is generating recognition of Helix within the investment community.
I missed out on the last opportunity to buy more at 80-85 cents but with the trading being thin I would expect volatility for a while yet. I did pick up some more shares a couple of weeks ago at a buck. Incidentally, Terry also bought more recently--I didn't ask how much but I do know that insiders hold a relatively large percentage of the outstanding shares. This along with the employee share option plan are two solid indicators of confidence in the company.
Dan Byrne
P.S. Some day we will both be very glad that we own HBP (and I hope RRK too!).
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext